Federation des caisses Desjardins du Quebec’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio ARLZ Stock Details ARLZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-5,247	Closed	-$1.8K	–	2246
2018 Q2	$1.8K	Buy	5,247 +1,673	+47%	+$1.37K	﹤0.01%	2028
2018 Q1	$5.12K	Hold	3,574	–	–	﹤0.01%	1859
2017 Q4	$5.03K	Sell	3,574 -363	-9%	-$596	﹤0.01%	1870
2017 Q3	$8.65K	Hold	3,937	–	–	﹤0.01%	1709
2017 Q2	$5K	Hold	3,937	–	–	﹤0.01%	1886
2017 Q1	$8.42K	Buy	+3,937	New	+$14.8K	﹤0.01%	1464

Other funds holding ARLZ

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Federation des caisses Desjardins du Quebec's ARLZ Position: Q3 2018 in Review

Federation des caisses Desjardins du Quebec sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q3 2018, closing a stake of 5,247 shares — an estimated $1.8K sold.

Federation des caisses Desjardins du Quebec first reported a position in ARLZ in Q1 2017 and held it in 6 quarters. The position peaked at $8.65K in Q3 2017. 4 funds tracked by Wall St. Rank hold ARLZ as of Q3 2018.

Federation des caisses Desjardins du Quebec reported no remaining Aralez Pharmaceuticals Inc. position as of Q3 2018 after selling out during the quarter.
Federation des caisses Desjardins du Quebec sold 5,247 Aralez Pharmaceuticals Inc. shares in Q3 2018, an estimated $1.8K.
Federation des caisses Desjardins du Quebec first reported a position in Aralez Pharmaceuticals Inc. in Q1 2017 and held it in 6 quarters.
Federation des caisses Desjardins du Quebec's Aralez Pharmaceuticals Inc. position peaked at $8.65K in Q3 2017.
4 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q3 2018.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q3 2018, filed 30 Aug 2024.